M. Moghaddam-Manesh, et al.
Bioorganic Chemistry 98 (2020) 103751
were synthesized and by using it spiro[indoline-3,4′-[1,3]dithiine]@Cu
same temperature. The black precipitates were removed by magnet and
(
NO
3
)
2
supported on Fe
3
O @gly@CE magnetic nanoparticle were
4
washed several times with water and ethanol and dried at ambient
synthesized and was used as a magnetic nanocatalysts in the synthesis
of 2-oxospiro[indoline-3,4′-[1,3]dithiine]-5′-carbonitrile derivatives .
The biological properties of these compounds such as antibacterial and
antifungal properties as well as their antioxidant activity were in-
vestigated.
temperature [39]. With the sonication, 1g of the prepared Fe
3
O @gly
4
was disperse in toluene (100 mL), then 8 mmol 6′-amino-2-oxo-2′-
(2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)spiro[indoline-3,4′-
[1,3]dithiine]-5′-carbonitrile (7a) was added under N atmosphere and
2
stirred at reflux temperature for 12 h. The precipitates were removed
with a magnet and dried over room temperature after several times
rinses with ethanol. 1 g of nanoparticles of the previous step were
dispersed in 100 mL EtOH under ultrasound conditions and 1.93 g Cu
The novelty in this work is the synthesis of new magnetic nano-
complexes and their application is in the synthesis of new bioactive
derivatives of 1,3-dithiane. The importance of these nanoparticles as
catalysts is their easy separability after reaction and reuse compared to
previously reported catalysts [29].
(NO
3
)
2
·3H O added to the mixture, then stirred and refluxed for 12 h
2
under N
2
atmosphere. The Fe
3
O
4
@gly@thiophen@Cu(NO
3
) with the
2
magnet were separated and after several times washing with water and
ethanol were dried at ambient temperature.
2
. Experimental section
2.1. General
2.5. Synthesis of products 7a-f in MNPs‑catalyzed condition
All chemicals and solvents were procured from Merck and Sigma-
A mixture of 1 mmol (0.066 g) malononitrile and 1 mmol isatine
derivatives in 2 mL acetonitrile was stirred at room temperature for
30 min. In the other container, 1 mmol barbituric acid derivatives,
3 mmol (0.2284 g) carbon disulphide and MNPs (10 mg) in 2 mL of
acetonitrile was stirred at room temperature for 30 min. Then, the
mixtures were added together and stirred at room temperature for
4.5–6.5 h. After completion of the reaction (monitoring with TLC n-
hexane/ethyl acetate), 10 mL acetonitrile was added to the mixture and
the catalyst was separated by an external magnet and washed with
EtOH and water, then the precipitates were separated and the pur-
ification was done by recrystal in acetonitrile.
Aldrich with high-grade quality and used without further purification.
Antibiotics were purchased from Sigma-Aldrich. Melting points were
recorded on a Kruss type KSP1 N melting point meter and uncorrected.
Monitoring progress of the reactions and the purity of the products
were affected by TLC and all yields refer to isolated products. A scan-
ning electron microscope (SEM) was applied to observe the surface
morphology of nanoparticles using a Hitachi S4160 instrument. The X-
ray diffraction (XRD) analysis was conducted by using a Bruker D8 X-
ray diffractometer with Cu-Kα radiation (λ = 1.5418 Å) in the range of
1
0–70° and the scanning rate of 1.5°/min. The IR spectra of the pro-
ducts were recorded on a Bruker Tensor 27 FT-IR spectrometer using
6′-amino-2-oxo-2′-(2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)
spiro[indoline-3,4′-[1,3]dithiine]-5′-carbonitrile (7a)
−
1
1
13
KBr disks with absorption in cm . The H and C NMR spectra of
DMSO-d solutions were recorded on a Bruker FT-NMR Ultra Shield-
−1
6
Light yellow powder; M.p. 210–212 °C; IR (KBr, cm ): 3144, 3011
1
4
00 spectrometer (250 and 75 MHz, resp.). Elemental analyses were
(NH , NH), 2255 (CN), 1667 (CO), 1581 (C]C). H NMR (250 MHz,
2
performed for C, H, N, and S on a Thermo Finnigan Flash EA micro-
analyzer. The concentration of bacterial and fungal suspensions was
determined by using Jenway 6405 UV–V is spectrophotometer.
DMSO-d ) δ: 6.72 (1H, d, J = 7.47 Hz, H-Ar), 6.83 (1H, t, J = 7.18 Hz,
6
H-Ar), 6.94 (2H, s, NH ), 7.11 (1H, t, J = 7.62 Hz, H-Ar), 7.29 (1H, d,
2
1
3
J = 7.12 Hz, H-Ar), 9.16 (2H, s, NH), 10.32 (1H, s, NH). C NMR
(
75 MHz, DMSO-d
6
) δ: 52.4, 82.0, 109.3, 113.8, 121.6, 123.9, 128.8,
2
.2. Synthesis of products 7a-f in base‑catalyzed conditions
131.8, 142.9, 151.9, 164.3, 177.1. Anal. Calcd for C H N O S : C,
1
6 9 5 4 2
4
8.11; H, 2.27; N, 17.53; S, 16.06. Found: C, 48.15; H, 2.26; N, 17.56; S,
16.02.
6′-amino-2′-(4,6-dioxo-2-thioxotetrahydropyrimidin-5(2H)-ylidene)-2-
A mixture of 1 mmol malononitrile (0.066 g) and 1 mmol isatine
derivatives was added to 2 mL of acetonitrile and stirred at ambient
temperature for 0.5 h. In another container, add 1 mmol of barbituric
acid derivatives, 3 mmol carbon disulfide (0.2284 g) and 2 mmol
triethylamine (0.2024 g) to 2 mL of acetonitrile and was stirred at
ambient temperature for 1 h. Then add the mixtures together and was
stirred at ambient temperature for 5–9 h. After completion of the re-
action (monitoring with TLC hexane/ethyl acetate), the precipitates
were separated and the purification was done by recrystal in acetoni-
trile.
oxospiro[indoline-3,4′-[1,3]dithiine]-5′-carbonitrile (7b)
−1
Light cream powder; M.p. 215–216 °C; IR (KBr, cm ): 3400 and
1
3154 (NH, NH ), 2194 (CN), 1722 (CO), 1587 (C]C). H NMR
2
(250 MHz, DMSO-d ) δ: 6.69–6.94 (4H, m, 2H-Ar and NH ), 7.13 (1H, t,
6
2
J = 7.50 Hz, H-Ar), 7.28 (1H, d, J = 7.0 Hz, H-Ar), 10.39 (1H, s, NH),
1
3
10.64 (2H, s, 2NH). C NMR (75 MHz, DMSO-d ) δ: 52.1, 90.4, 109.3,
6
113.6, 118.6, 123.6, 128.0, 129.1, 131.0, 135.5, 142.6, 160.8, 162.1,
173.7, 178.5, 179.1. Anal. Calcd for C H N O S : C, 46.25; H, 2.18; N,
16 9 5 3 3
1
6.86; S, 23.16. Found: C, 46.22; H, 2.20; N, 16.88 0.53; S, 23.17.
2
.3. Computational studies
6′-amino-5-chloro-2-oxo-2′-(2,4,6-trioxotetrahydropyrimidin-5(2H)-
ylidene)spiro[indoline-3,4′-[1,3]dithiine]-5′-carbonitrile (7c)
−1
By using Gaussian 09 program package at 298.15 K and 1 atm,
Light cream powder; M.p. 212–213 °C; IR (KBr, cm ): 3370, 3170
1
geometrie of 7a were optimized at the B3LYP level of theory in con-
(NH
2
, NH), 2257 (CN), 1702, 1683 (CO), 1585 (C]C). H NMR
**
junction with 6-311++G basis set and no molecular symmetry con-
straint was considered [38].
(250 MHz, DMSO-d
NH ), 7.17 (1H, d, J = 8.25 Hz, H-Ar), 7.29 (1H, s, H-Ar), 9.29 (s, 2H,
NH), 10.42 (1H, s, NH). C NMR (75 MHz, DMSO-d
110.7, 113.6, 123.9, 125.3, 125.8, 127.9, 128.7, 133.7, 141.6, 141.9,
6
) δ: 6.75 (1H, d, J = 8.0 Hz, H-Ar), 6.91 (2H, s,
2
1
3
6
) δ: 52.6, 81.8,
2
.4. Synthesis of spiro[indoline-3,4′-[1,3]dithiine]@Cu(NO
3
2
) supported
on Fe @gly@CE magnetic nanoparticles
3
O
4
151.9, 164.2, 176.8. Anal. Calcd for C16
H
8
5
ClN O
4 2
S
: C, 44.29; H, 1.86;
N, 16.14; S, 14.78. Found: C, 44.33; H, 1.85; N, 16.12; S, 14.77.
6′-amino-5-chloro-2′-(4,6-dioxo-2-thioxotetrahydropyrimidin-5(2H)-
ylidene)-2-oxospiro[indoline-3,4′-[1,3]dithiine]-5′-carbonitrile (7d)
FeCl ·4H O (1.988 g) and FeCl ·6H O (5.406 g) were dissolved in
2
2
3
2
8
0 mL of water and stirred at 1000 rpm under N
2
atmosphere.
−1
Temperature was slowly increased to 70 °C under and stirred at the
same temperature for 30 min, 30 mL of 25% ammonia solution was
added to the reaction mixture and stirred for 30 min at the same tem-
perature. 4 mL aqueous solution (0.3 g/mL) of glycine was added and
the temperature was slowly raised to 90 °C, and stirred for 60 min at
Light cream powder; M.p. 224–226 °C; IR (KBr, cm ): 3220, 3174
1
(NH
2
, NH), 2194 (CN), 1729, 1656 (CO), 1501 (C]C). H NMR
(250 MHz, DMSO-d
Ar), 7.05 (2H, s, NH
NH), 10.85 (1H, s, NH). C NMR (75 MHz, DMSO-d
6
) δ: 6.73 (1H, d, J = 8.25 Hz, H-Ar), 6.94 1H, s, H-
2
), 7.12 (1H, d, J = 8.0 Hz, H-Ar), 10.37 (s, 2H,
1
3
6
) δ: 48.4, 89.7,
2